Back to medical news
MedPage Today
OTC Alpha-Agonist Drops for Eye Redness Get FDA Green Light
October 16, 2026
Original source summary
(MedPage Today) -- The FDA announced approval of apraclonidine ophthalmic solution 0.125% (Brytly) as an over-the-counter treatment for eye redness related to minor irritations. The approval specifies use of the topical agent by adults and children...
Verbatim from MedPage Today's own feed — "OTC Alpha-Agonist Drops for Eye Redness Get FDA Green Light"
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
More medical news